Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Depression, Emergency Medicine


Basics


Description


Major depression:  
  • Depressed mood and associated signs and symptoms lasting more than 2 wk
  • Significant morbidity and mortality, including risk of suicide
  • Often coexists with other medical illness

Etiology


  • Biologic illness associated with derangements in several neurotransmitter systems including serotonin, norepinephrine, and dopamine
  • Contributing factors:
    • Genetic predisposition
    • Medical illness
    • Medication effects
    • Psychosocial stress: Depression may follow adverse life event, trauma, loss of important relationship, or life role
  • Higher prevalence in women. (Woman make more suicide attempts; men are more likely to complete suicide successfully)

Diagnosis


Signs and Symptoms


  • 5 or more symptoms for at least 2 wk. (One of the symptoms must be depressed mood or loss of interest or pleasure):
    • Depressed mood
    • Diminished interest or pleasure
    • Change in appetite, weight loss/gain
    • Sleep disturbance
    • Fatigue or loss of energy
    • Diminished concentration
    • Feeling of worthlessness or guilt
    • Recurrent thoughts of death or suicide
    • Psychomotor agitation or retardation
  • Subtypes: Psychotic features, melancholic, catatonic, atypical, postpartum, seasonal
  • May be anxious/agitated or withdrawn
  • Associated somatic complaints:
    • Weakness, malaise
    • Weight loss
    • Headache, back pain

History
  • Time course, acuity, stressors
  • Review depressive symptoms (see above)
  • Past medical history
  • Past psychiatric history
  • Medications (prescribed and over-the-counter)
  • Substance use
  • Family history
  • Social and occupational history; losses, transitions, trauma, and other major life events
  • Safety assessment:
    • Suicide risk
    • Risk of violence to others
    • Assess ability to care for self, nutrition
  • Collateral from family or outpatient providers
  • Cultural and language differences may complicate evaluation; use interpreter when appropriate

Physical Exam
  • Vital signs
  • Neurologic exam:
    • Motor exam: Station, gait, strength, tone, abnormal movements
    • Cognitive exam: Orientation, attention, memory, language, executive function
  • Mental status exam: Affect and mood, thought form and content

  • Depression may be difficult to diagnose in children and adolescents. Indicators of major depression in children may include:
    • Changes in school, home, and social functioning
    • Changes in sleep
    • Social withdrawal
    • Somatic complaints
  • Consult with a child psychiatrist

Rule-out bipolar disorder: May require different treatment (mood stabilizers, antipsychotics), also antidepressants may precipitate mania in bipolar patients  

Essential Workup


  • Identify signs and symptoms of major depression (see "Signs and Symptoms"¯)
  • Use history and physical exam to guide further workup
  • Rule-out associated or coexisting psychiatric and medical conditions, substance use
  • Safety assessment

Diagnosis Tests & Interpretation


Lab
  • 1st line:
    • CBC; chemistries including electrolytes, BUN/creatinine, glucose, calcium, liver function tests
    • Urinalysis
    • Serum and urine toxicology screen
    • Thyroid function tests
    • B12 and folate
  • 2nd line, guided by history and initial findings:
    • HIV testing
    • RPR
    • ESR/CRP/ANA

Imaging
  • Brain imaging: Recommended for atypical presentation or if focal neurologic findings
  • MRI brain preferred over CT for detecting tumors, cerebrovascular accident, white matter changes

Differential Diagnosis


  • Psychiatric illnesses:
    • Dysthymic disorder
    • Adjustment disorder
    • Bipolar disorder
    • Anxiety disorders, including acute stress reactions, PTSD
    • Schizophrenia, schizoaffective disorder
    • Personality disorder
    • Eating disorder
    • Substance-induced mood disorder
  • Medical conditions that may cause or mimic depression:
    • Drug induced:
      • Antihypertensives
      • Oral contraceptives
      • Steroids
      • Sedative-hypnotics
      • Opioids
      • Psychostimulants (in withdrawal phase)
      • β-Blockers
      • Metoclopramide
    • Endocrine disorders:
      • Hypothyroidism
      • Adrenal insufficiency
      • Diabetes mellitus
      • Postpartum, perimenopausal, and premenstrual syndromes
    • Tumors:
      • Pancreatic
      • Lung
      • Brain
    • Neurologic disorders:
      • Dementia (early phase or frontal type)
      • Epilepsy
      • Parkinson disease
      • Multiple sclerosis
      • Huntington disease
      • Stroke
      • Head trauma; subdural hematoma
      • Normal pressure hydrocephalus
    • Infections:
      • Hepatitis
      • HIV
      • Mononucleosis
    • Nutritional disorders:
      • Folate deficiency
      • Pellagra
      • Vitamin B12 deficiency
    • Electrolyte disturbances
    • End-stage renal, hepatic, pulmonary, and cardiovascular diseases
    • Obstructive sleep apnea
    • Chronic pain syndromes

Treatment


Pre-Hospital


  • Ensure safety of patient and providers
  • Understand local laws for involuntary commitment to hospital

Initial Stabilization/Therapy


  • Safety: Assess risk of suicide, violence
  • General medical evaluation
  • Management:
    • 1-to-1 observation and suicide precautions when appropriate
    • Work up potential medical causes

Ed Treatment/Procedures


  • Psychological management:
    • Listen empathically to understand context and relevant stressors
    • Reassurance and education (e.g., depression is a treatable condition)
  • Initiate medications:
    • Antidepressant medication may be initiated for some patients with clear diagnosis and established follow-up
    • Usually takes weeks for antidepressant medications to resolve major depression
    • Low-dose benzodiazepines or neuroleptics may be used for associated agitation, insomnia, or psychosis
  • Choice of drug determined by:
    • Indications, efficacy
    • Side-effect profile and risks
    • Convenience, cost, availability
  • Selective serotonin reuptake inhibitors (SSRIs: fluoxetine, paroxetine, sertraline, citalopram, escitalopram):
    • Well tolerated
    • Side effects may include:
      • Mild nausea
      • Headache
      • Anxiety, restlessness, insomnia
      • Somnolence
      • Sexual dysfunction
      • Weight gain
    • Minimal overdose risk
  • Serotonin norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine):
    • Well tolerated
    • May be helpful for some pain syndromes
    • Side effects similar to SSRIs
  • Dopaminenorepinephrine reuptake inhibitor (bupropion):
    • Agitation, insomnia
    • Tremor
    • Decreased seizure threshold
    • Well-tolerated; no sexual side effects
  • Norepinephrine serotonin modulator (mirtazapine):
    • Weight gain
    • Sedation
    • Orthostasis
    • Constipation
  • Tricyclic antidepressants (amitriptyline, imipramine, nortriptyline, clomipramine):
    • Anticholinergic effects
    • Weight gain
    • Postural hypotension
    • Sedation
    • Decreased seizure threshold
    • Cardiac risk; overdose can be fatal
    • Nortriptyline is best tolerated
  • Monoamine oxidase inhibitors (phenelzine, tranylcypromine, selegiline transdermal):
    • Dietary and other medication restrictions to avoid hypertensive crisis
    • Dangerous in overdose

Medication


Medication dosage ranges are for adults.  
Dose may be titrated over weeks as indicated.  
  • Amitriptyline: Initial 25-50 mg/d PO
  • Bupropion: 75-400 mg/d PO
  • Citalopram: 20-40 mg/d PO
  • Desvenlafaxine: 50 mg/d PO
  • Duloxetine: 30-120 mg/d PO
  • Escitalopram: 10-20 mg/d PO
  • Fluoxetine: 20-60 mg/d PO
  • Imipramine: Initial 25-50 mg/d PO
  • Mirtazapine: 15-45 mg/d PO
  • Nortriptyline: Initial 25 mg/d PO
  • Paroxetine: 20-40 mg/d PO
  • Phenelzine: 15-90 mg/d PO
  • Sertraline: 50-200 mg/d PO
  • Tranylcypromine: 10-60 mg/d PO
  • Venlafaxine: 75-300 mg/d PO

First Line
SSRIs, SNRIs, bupropion, mirtazapine  
Second Line
  • Tricyclics and monoamine oxidase inhibitors
  • Use with caution in geriatric or medically ill
  • Consider ECT for severe or treatment-resistant depression, psychotic depression, or catatonia

  • Older patients may require lower dose; pay careful attention to potential drug interactions
  • Caution with orthostatic hypotension and cholinergic blockade

FDA "Black box"¯ warning: Antidepressants may increase risk of suicidal thinking and behavior in some children, adolescents, or young adults with depression  
In pregnant or breast-feeding women pay special attention to risks and benefits of medication treatments-consider consultation with a specialist in perinatal psychiatry  

Follow-Up


Disposition


Admission Criteria
  • Patient is suicidal or at high risk for suicide. See "Suicide, Risk Evaluation"¯
  • Minimal or unreliable social supports
  • Symptoms so severe that continual observation or nursing supportive care is required
  • Psychotic features
  • Civil commitment for psychiatric hospitalization is necessary if the patient is refusing treatment and is at risk to harm self or others

Discharge Criteria
  • Low suicide risk
  • Adequate social support
  • Close follow-up available

Issues for Referral
  • Outpatient mental health appointments and/or partial (day) hospital for patients not admitted
  • Insurance carrier may determine inpatient disposition and options for other levels of care
  • Case management or social services in ED may be helpful for disposition issues
  • Communicate and coordinate care with other providers including primary care

Followup Recommendations


Follow-up depends on severity of illness and risk:  
  • If not admitted, patients with significant symptoms should follow up in 1-2 wk
  • When medication is initiated, patient should be seen in follow-up in 1-2 wk
  • More stable patients or those with minor symptoms may be seen with less urgency

Pearls and Pitfalls


  • Patients with depression experience significant morbidity and may present a risk of self-harm
  • Consider other conditions that mimic depression; also coexisting psychiatric and medical conditions, substance use
  • Know hospitalization and involuntary commitment criteria in your area

Additional Reading


  • American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. Am J Psychiatry.  2010;167(suppl 10):1-152.
  • Belmaker  RH, Agam  G. Major depressive disorder. N Engl J Med.  2008;358:55-68.
  • Cassem  NH. Mood disordered patients. In: Stern  TA, Fricchione  GL, Cassem  NH, eds. MGH Handbook of General Hospital Psychiatry. 6th ed. St. Louis, MO: Mosby; 2010.
  • Stewart  DE. Clinical practice. Depression during pregnancy. N Engl J Med.  2011;365:1605-1611.

See Also (Topic, Algorithm, Electronic Media Element)


  • Bipolar Disorder
  • Psychosis, Medical vs. Psychiatric
  • Psychiatric Commitment
  • Suicide, Risk Evaluation

Codes


ICD9


  • 296.20 Major depressive affective disorder, single episode, unspecified
  • 296.24 Major depressive affective disorder, single episode, severe, specified as with psychotic behavior
  • 296.30 Major depressive disorder, recurrent episode, unspecified degree
  • 648.40 Mental disorders of mother, unspecified as to episode of care or not applicable
  • V62.84 Suicidal ideation

ICD10


  • F32.3 Major depressv disord, single epsd, severe w psych features
  • F32.9 Major depressive disorder, single episode, unspecified
  • F33.9 Major depressive disorder, recurrent, unspecified
  • F53 Puerperal psychosis
  • R45.851 Suicidal ideations

SNOMED


  • 35489007 Depressive disorder (disorder)
  • 370143000 major depressive disorder (disorder)
  • 73867007 Severe major depression with psychotic features (disorder)
  • 58703003 postpartum depression (disorder)
  • 267073005 Suicidal (finding)
  • 320751009 Major depression, melancholic type (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer